Determinants of survival in idiopathic pulmonary fibrosis
- PMID: 8306044
- DOI: 10.1164/ajrccm.149.2.8306044
Determinants of survival in idiopathic pulmonary fibrosis
Abstract
To identify the determinants of survival in patients with idiopathic pulmonary fibrosis (IPF), we performed a survival analysis on 74 subjects with IPF. The study subjects were on average 64 yr of age (range, 25 to 83 yr), 62% were male, and 29% were never smokers. A tissue diagnosis was made in 67 (91%) of our study subjects. These subjects were followed for a mean period of 4 yr (range, 1.4 to 118.8 months) after the onset of pulmonary symptoms. During the period of observation, 41 subjects died (median survival = 28.2 months) and 33 continue to survive (median follow-up period = 60.9 months). A univariate analysis demonstrated that diminished survival was significantly associated with male gender (hazard ratio = 1.98; 95% confidence interval [CI] = 1.01-3.85), a higher FEV1/FVC ratio (hazard ratio = 1.82 [per 10% increase in the FEV1/FVC ratio]; 95% CI = 1.21-2.73), a lower percent predicted FVC (hazard ratio = 0.74; 95% CI = 0.60-0.91), a lower percent predicted total lung capacity (TLC) (hazard ratio = 0.75; 95% CI = 0.60-0.94), a lower percent predicted diffusing capacity of carbon monoxide (DLCO) (hazard ratio = 0.69; 95% CI = 0.53-0.89), a higher ILO profusion category on chest radiograph (hazard ratio = 3.52; 95% CI = 1.58-7.87), and an enhanced release of prostaglandin E2 (PGE2) by cultured alveolar macrophages (hazard ratio = 1.32 [per 10 pm/ml of PGE2]; 95% CI = 1.07-1.62).(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Determinants of progression in idiopathic pulmonary fibrosis.Am J Respir Crit Care Med. 1994 Feb;149(2 Pt 1):444-9. doi: 10.1164/ajrccm.149.2.8306043. Am J Respir Crit Care Med. 1994. PMID: 8306043
-
Surfactant protein A predicts survival in idiopathic pulmonary fibrosis.Am J Respir Crit Care Med. 1995 Aug;152(2):751-9. doi: 10.1164/ajrccm.152.2.7633738. Am J Respir Crit Care Med. 1995. PMID: 7633738
-
[Cell profiles of bronchoalveolar lavage fluid as prognostic indicators of idiopathic pulmonary fibrosis].Zhonghua Jie He He Hu Xi Za Zhi. 2008 Apr;31(4):260-3. Zhonghua Jie He He Hu Xi Za Zhi. 2008. PMID: 18846961 Chinese.
-
Idiopathic pulmonary fibrosis: outcome in relation to smoking status.Am J Respir Crit Care Med. 2008 Jan 15;177(2):190-4. doi: 10.1164/rccm.200612-1759OC. Epub 2007 Oct 25. Am J Respir Crit Care Med. 2008. PMID: 17962635
-
Determinants of response to immunosuppressive therapy in idiopathic pulmonary fibrosis.Eur Respir J. 1994 Nov;7(11):1950-7. Eur Respir J. 1994. PMID: 7875264
Cited by
-
Idiopathic Pulmonary Fibrosis and the Elderly: Diagnosis and Management Considerations.Drugs Aging. 2016 May;33(5):321-34. doi: 10.1007/s40266-016-0366-1. Drugs Aging. 2016. PMID: 27083934
-
Epidemiology and management of common pulmonary diseases in older persons.J Gerontol A Biol Sci Med Sci. 2012 Mar;67(3):276-91. doi: 10.1093/gerona/glr251. Epub 2012 Feb 15. J Gerontol A Biol Sci Med Sci. 2012. PMID: 22337938 Free PMC article. Review.
-
Cigarette smoke and bleomycin-induced pulmonary oxidative stress in rats.Exp Ther Med. 2012 Jul;4(1):121-124. doi: 10.3892/etm.2012.550. Epub 2012 Apr 17. Exp Ther Med. 2012. PMID: 23060934 Free PMC article.
-
Gender-based differences in bleomycin-induced pulmonary fibrosis.Am J Pathol. 2005 Jun;166(6):1593-606. doi: 10.1016/S0002-9440(10)62470-4. Am J Pathol. 2005. PMID: 15920145 Free PMC article.
-
Secreted Phosphoprotein 1 and Sex-Specific Differences in Silica-Induced Pulmonary Fibrosis in Mice.Environ Health Perspect. 2016 Aug;124(8):1199-207. doi: 10.1289/ehp.1510335. Epub 2016 Mar 8. Environ Health Perspect. 2016. PMID: 26955063 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical